美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA212512"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71839-106-24 71839-106 HUMAN PRESCRIPTION DRUG Neostigmine methylsulfate Neostigmine methylsulfate INJECTION INTRAVENOUS 20190513 N/A ANDA ANDA212512 BE Pharmaceuticals Inc. NEOSTIGMINE METHYLSULFATE 1 mg/mL 24 CARTON in 1 CARTON (71839-106-24) / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-106-01) / 10 mL in 1 VIAL, MULTI-DOSE
71839-106-10 71839-106 HUMAN PRESCRIPTION DRUG Neostigmine methylsulfate Neostigmine methylsulfate INJECTION INTRAVENOUS 20220317 N/A ANDA ANDA212512 BE Pharmaceuticals Inc. NEOSTIGMINE METHYLSULFATE 1 mg/mL 10 VIAL, MULTI-DOSE in 1 CARTON (71839-106-10) / 10 mL in 1 VIAL, MULTI-DOSE
71839-105-24 71839-105 HUMAN PRESCRIPTION DRUG Neostigmine methylsulfate Neostigmine methylsulfate INJECTION INTRAVENOUS 20190513 N/A ANDA ANDA212512 BE Pharmaceuticals Inc. NEOSTIGMINE METHYLSULFATE .5 mg/mL 24 CARTON in 1 CARTON (71839-105-24) / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-105-01) / 10 mL in 1 VIAL, MULTI-DOSE
71839-105-10 71839-105 HUMAN PRESCRIPTION DRUG Neostigmine methylsulfate Neostigmine methylsulfate INJECTION INTRAVENOUS 20220317 N/A ANDA ANDA212512 BE Pharmaceuticals Inc. NEOSTIGMINE METHYLSULFATE .5 mg/mL 10 VIAL, MULTI-DOSE in 1 CARTON (71839-105-10) / 10 mL in 1 VIAL, MULTI-DOSE
31722-994-31 31722-994 HUMAN PRESCRIPTION DRUG neostigmine methylsulfate neostigmine methylsulfate INJECTION INTRAVENOUS 20210104 N/A ANDA ANDA212512 Camber Pharmaceuticals Inc. NEOSTIGMINE METHYLSULFATE .5 mg/mL 10 VIAL, MULTI-DOSE in 1 CARTON (31722-994-31) / 10 mL in 1 VIAL, MULTI-DOSE
31722-995-31 31722-995 HUMAN PRESCRIPTION DRUG neostigmine methylsulfate neostigmine methylsulfate INJECTION INTRAVENOUS 20210104 N/A ANDA ANDA212512 Camber Pharmaceuticals Inc. NEOSTIGMINE METHYLSULFATE 1 mg/mL 10 VIAL, MULTI-DOSE in 1 CARTON (31722-995-31) / 10 mL in 1 VIAL, MULTI-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase